These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 3088639

  • 1. Dissociation of the anorectic actions of 5-HTP and fenfluramine.
    Fletcher PJ, Burton MJ.
    Psychopharmacology (Berl); 1986; 89(2):216-20. PubMed ID: 3088639
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors.
    Neill JC, Cooper SJ.
    Psychopharmacology (Berl); 1989; 97(2):213-8. PubMed ID: 2498930
    [Abstract] [Full Text] [Related]

  • 4. The anorectic action of peripherally administered 5-HT is enhanced by vagotomy.
    Fletcher PJ, Burton MJ.
    Physiol Behav; 1985 Jun; 34(6):861-6. PubMed ID: 4059374
    [Abstract] [Full Text] [Related]

  • 5. Effects of 5-hydroxytryptamine and d-fenfluramine on sham feeding and sham drinking in the gastric-fistulated rat.
    Neill JC, Cooper SJ.
    Physiol Behav; 1989 Dec; 46(6):949-53. PubMed ID: 2634259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
    Lawton CL, Blundell JE.
    Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R, Miranda GF, Verry M.
    Int J Obes; 1984 Oct; 8 Suppl 1():103-17. PubMed ID: 6549508
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine.
    Groppetti A, Parenti M, Dellavedova L, Tirone F.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):446-53. PubMed ID: 6694120
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
    Shukla R, MacKenzie-Taylor D, Rech RH.
    Psychopharmacology (Berl); 1990 Feb; 100(1):115-8. PubMed ID: 2296618
    [Abstract] [Full Text] [Related]

  • 15. Effects of dl-fenfluramine and xylamidine on gastric emptying of maintenance diet in freely feeding rats.
    Baker BJ, Duggan JP, Barber DJ, Booth DA.
    Eur J Pharmacol; 1988 May 20; 150(1-2):137-42. PubMed ID: 3402534
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cyclo(His-Pro) potentiates the reduction of food intake induced by amphetamine, fenfluramine, or serotonin.
    Kow LM, Pfaff DW.
    Pharmacol Biochem Behav; 1991 Feb 20; 38(2):365-9. PubMed ID: 2057504
    [Abstract] [Full Text] [Related]

  • 19. Peripheral serotonergic inhibition of suckling.
    Bateman ST, Lichtman AH, Cramer CP.
    Pharmacol Biochem Behav; 1990 Oct 20; 37(2):219-25. PubMed ID: 2080185
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.